Acute heart failure with preserved ejection fraction: Unique patient characteristics and targets for therapy

被引：27

作者：

Bishu K. ^{[1
]}

Redfield M.M. ^{[1
]}

机构：

[1] Mayo Clinic Cardiovascular Research, Rochester, MN 55905, Guggenheim 9

来源：

Current Heart Failure Reports | 2013年 / 10卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Heart failure with preserved ejection fraction;

D O I：

10.1007/s11897-013-0149-5

中图分类号：

学科分类号：

摘要：

Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to 53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF. © 2013 Springer Science+Business Media New York.

引用

页码：190 / 197

页数：7

共 59 条

[1]

Heidenreich P.A., Albert N.M., Allen L.A., Bluemke D.A., Butler J., Fonarow G.C., Et al., Forecasting the impact of heart failure in the United States: A policy statement from the american heart association, Circ Heart Fail, 6, 3, pp. 606-619, (2013)

[2]

Gheorghiade M Z., Acute heart failure syndromes: Current state and framework for future research, Circulation, pp. 3958-3968, (2005)

[3]

Felker G.M., Pang P.S., Adams K.F., Cleland J.G.F., Cotter G., Dickstein K., Et al., Clinical trials of pharmacological therapies in acute heart failure syndromes: Lessons learned and directions forward, Circ Heart Fail, 3, 2, pp. 314-325, (2010)

[4]

Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Et al., Heart disease and stroke statistics - 2013 update a report from the American Heart Association, Circulation, (2012)

[5]

Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M., Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, 355, 3, pp. 251-259, (2006)

[6]

Chinali M., Joffe S.W., Aurigemma G.P., Makam R., Meyer T.E., Goldberg R.J., Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: The Worcester Heart Failure Study, Coron Artery Dis, 21, 3, pp. 137-143, (2010)

[7]

Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Et al., Outcome of heart failure with preserved ejection fraction in a population-based study, N Engl J Med, 355, 3, pp. 260-269, (2006)

[8]

Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., Fonarow G.C., Clinical presentation, management, and in-hospital outcomes of patients admitted with Acute Decompensated Heart Failure with preserved systolic function, J Am Coll Cardiol, 47, 1, pp. 76-84, (2006)

[9]

Fonarow G.C., Stough W.G., Abraham W.T., Albert N.M., Gheorghiade M., Greenberg B.H., Et al., Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF Registry, J Am Coll Cardiol, 50, 8, pp. 768-777, (2007)

[10]

Sweitzer N.K., Lopatin M., Yancy C.W., Mills R.M., Stevenson L.W., Comparison of clinical features and outcomes of patients hospitalized with Heart Failure and Normal Ejection Fraction (≥55%) Versus those with mildly reduced (40% to 55%) and moderately to severely reduced, Am J Cardiol, 101, 8, pp. 1151-1156, (2008)

← 1 2 3 4 5 6 →